FABTECH · NSE
Fabtech Technologies Limited
₹147.93
+0.69% (+₹1.01)
Prev. close
₹146.92
Volume
41,486
Delivery %
52.1%
As of
18 Sept 2026
Price history
No analyst calls on this stock in the last 90 days yet.
Explore by date range →Analyst opinions
Fundamentals
About Fabtech Technologies Limited
Fabtech Technologies Limited operates as a biopharma engineering company that provides aseptic manufacturing facilities internationally. The company offers designing, engineering, procurement, installation, and testing of pharmaceutical equipment. It serves pharmaceuticals, biotech, and healthcare companies. The company was founded in 2001 and is based in Mumbai, India.
Details
Sector
Healthcare
Industry
Health Information Services
CEO
Mr. Ashwani Kumar Singh
Headquarters
Mumbai
Employees
186
Website
fabtechnologies.comExchange
View on NSE ↗Key stats
Market cap
₹657.56 Cr
P/E ratio (TTM)
13.5
Dividend yield
0.41%
EPS (TTM)
₹10.96
Beta (1Y · daily vs NIFTY 50)
1.06
Shares float
90.64 L
EPS · quarter ended Jun 2026
₹0.95
Financial Performance
01 · Financials
FY23 growth needs FY22 filings, which the data source doesn't provide.
02 · Earnings Per Share (EPS)
03 · Dividend Profile
Growth compares completed fiscal-year dividend totals on the company's own calendar: April–March (Indian FY), taken from its reported period-ends. Payout ledger: NSE corporate actions.
04 · Operating Efficiency (Growth Rates)
Balance-sheet-based · pre-FY23 not filed in verifiable form
05 · Capital Structure & Asset Utilization
Pre-FY23 not filed in verifiable form
Asset turnover needs a prior year of assets — omitted for the earliest available year.
06 · Asset Base Composition
Pre-FY23 not filed in verifiable form
07 · Debt Level & Coverage
Pre-FY23 not filed in verifiable form
08 · Profit & Loss
Annual
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| — | — | — | ₹193.80 Cr | ₹226.14 Cr | ₹322.46 Cr | ₹410.77 Cr | |
| EBITDA | — | — | — | ₹32.38 Cr | ₹39.75 Cr | ₹64.76 Cr | ₹57.33 Cr |
| — | — | — | ₹21.73 Cr | ₹27.22 Cr | ₹46.45 Cr | ₹38.36 Cr | |
| Diluted EPS | — | — | — | — | — | ₹10.45 | ₹10 |
Revenue, Total expenses (as filed), Employee benefit expense, Depreciation & amortisation, Other expenses, EBITDA, Net income, Tax provision, Interest expense, Other income, Diluted EPS have filed figures for only some of the years shown — no further verified source covers the rest, so those years are left blank rather than estimated.
09 · Balance Sheet
Annual
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| — | — | — | ₹213.86 Cr | ₹269.24 Cr | ₹426.56 Cr | ₹690.89 Cr | |
| — | — | — | ₹35.45 Cr | ₹12.71 Cr | ₹83.83 Cr | ₹69.63 Cr | |
| Stockholders' equity | ₹38.01 Cr | ₹46.01 Cr | ₹68.00 Cr | ₹89.00 Cr | ₹132.00 Cr | ₹173.00 Cr | ₹419.00 Cr |
Total assets, Current assets, Trade receivables, Cash & equivalents, Non-current assets, Total debt, Long-term debt, Current (short-term) debt, Others have filed figures for only some of the years shown — no further verified source covers the rest, so those years are left blank rather than estimated.
Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.
10 · Cash Flow Statement
Annual
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| — | — | — | ₹-13.89 Cr | ₹60.43 Cr | ₹-36.14 Cr | ₹47.74 L | |
| Investing cash flow | — | — | — | ₹1.89 Cr | ₹-30.00 Cr | ₹-20.05 Cr | ₹-112.31 Cr |
| ₹-23.00 Cr | ₹6.00 Cr | ₹8.00 Cr | ₹12.00 Cr | ₹-12.00 Cr | ₹36.00 Cr | ₹190.00 Cr | |
| Capital expenditure | — | — | — | ₹-32.37 L | ₹-1.22 Cr | ₹-24.78 Cr | ₹-4.71 Cr |
| End cash position | — | — | — | ₹10.53 Cr | ₹28.99 Cr | ₹9.06 Cr | ₹86.88 Cr |
Operating cash flow, Depreciation & amortization, Investing cash flow, Debt issued, Debt repaid, Dividends paid, Capital expenditure, End cash position have filed figures for only some of the years shown — no further verified source covers the rest, so those years are left blank rather than estimated.
Annual only — the data source has no quarterly cash-flow-statement coverage.
11 · Shareholding Pattern
NSE, quarterly
| Line item | Oct 25–Jun 26(4Q) |
|---|---|
| Promoter | 68.94% |
| Public | 31.06% |
| Employee trusts | 0.00% |
Source: NSE quarterly shareholding-pattern filings, collapsed to periods where the reported percentages held steady — a column spanning several quarters means no change was filed across them. No FII/DII sub-split available from this source — Public includes all non-promoter, non-employee-trust holders.
12 · Peer Comparison
Healthcare
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4.48 L Cr | ₹1,837.3 | 37.0 | 5.36 | 13.7% | 0.06 | +11.9% | +11.4% |
| Divi's Laboratories Limited | ₹2.47 L Cr | ₹9,375 | 83.3 | 14.77 | 15.3% | 0.00 | +12.3% | +53.4% |
| Torrent Pharmaceuticals Limited | ₹1.83 L Cr | ₹4,875 | 76.9 | 21.82 | 25.8% | 1.79 | +21.5% | +37.4% |
| Apollo Hospitals Enterprise Limited | ₹1.26 L Cr | ₹8,944.5 | 60.4 | 13.30 | 20.5% | 0.90 | +15.7% | +13.9% |
| Lenskart Solutions Limited | ₹1.18 L Cr | ₹707.2 | 179.9 | 13.48 | 5.6% | 0.35 | +35.4% | — |
| Zydus Lifesciences Limited | ₹1.13 L Cr | ₹1,160 | 25.3 | 4.18 | 18.6% | 0.46 | +18.4% | +10.7% |
| Cipla Limited | ₹1.10 L Cr | ₹1,376.3 | 32.5 | 3.19 | 11.3% | 0.02 | +2.1% | -11.8% |
| Laurus Labs Limited | ₹1.05 L Cr | ₹1,954 | 96.4 | 19.86 | 16.8% | 0.48 | +22.0% | +111.6% |
| Max Healthcare Institute Limited | ₹1.01 L Cr | ₹1,049.3 | 69.8 | 9.39 | 13.4% | 0.32 | +19.0% | -10.6% |
| Dr. Reddy's Laboratories Limited | ₹97,876.16 Cr | ₹1,185 | 29.6 | 2.60 | 11.4% | 0.21 | +3.2% | -10.4% |
| Manipal Health Enterprises Limited | ₹97,364.22 Cr | ₹738.95 | 146.6 | 11.56 | 7.8% | 1.53 | +18.0% | — |
| Fabtech Technologies Limited | ₹649.87 Cr | ₹147.02 | 13.4 | 1.55 | 9.1% | 0.17 | +26.8% | — |
Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.
Documents
IPO documents
Annual reports
Concall transcripts
Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.
Index membership
4 indices
NSE weights are a free-float market-cap-share estimate, not NSE’s own published (and sometimes capped) index weight. BSE weights are BSE’s own published index weight, not an estimate. Indices without weight data are listed without one, in alphabetical order after the weighted ones.
Fabtech Technologies surges on bagging Rs 21 crore turnkey project
Investment Guru India · 23 hours ago